Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duo Wan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|June 12, 2026
Underwater Robot Object Detection Algorithm Based on YOLOv11Yongqing Shi, Wei Chen, Duo Wan, et al.
BMC Medicine|February 24, 2026
Targeting cancer stem cells predicts response and reverses chemoresistance in ascites-derived ovarian cancer organoidsXiaoli Zhang, Wen Zhang, Ying Cui, et al.
Geriatrics & Gerontology International|December 6, 2019
Factors associated with preferences for elderly care mode and choice of caregivers among parents who lost their only child in a central China cityChao Rong, Duo Wan, Cai-Ming Xu, et al.
Discover Oncology|December 18, 2024
Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancerPeipei Xie, Xiaoli Zhang, Tianyi Liu, et al.
Cancer Letters|February 28, 2024
Circulating tumor cell clustering modulates RNA splicing and polyadenylation to facilitate metastasisQuanyou Wu, Zhaoru Gu, Bingqing Shang, et al.
Molecular Therapy. Oncology|April 16, 2025
Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activationDuo Wan, Qi Zhang, Zhenrong Yang, et al.
Journal of Hematology & Oncology|November 22, 2024
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinomaQi Zhang, Xiaoli Zhang, Zhuoheng Lv, et al.
Molecular Biomedicine|December 19, 2025
Peripheral TERT- positive leukocytes as a biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progressionQi Zhang, Xiaoli Zhang, Guoliang Li, et al.
BMC Medicine|October 31, 2022
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironmentDefeng Kong, Zhenrong Yang, Guoliang Li, et al.
Theranostics|November 28, 2022
Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapyQuanyou Wu, Xiao Hu, Xiaoli Zhang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|June 12, 2026
Underwater Robot Object Detection Algorithm Based on YOLOv11Yongqing Shi, Wei Chen, Duo Wan, et al.
BMC Medicine|February 24, 2026
Targeting cancer stem cells predicts response and reverses chemoresistance in ascites-derived ovarian cancer organoidsXiaoli Zhang, Wen Zhang, Ying Cui, et al.
Geriatrics & Gerontology International|December 6, 2019
Factors associated with preferences for elderly care mode and choice of caregivers among parents who lost their only child in a central China cityChao Rong, Duo Wan, Cai-Ming Xu, et al.
Discover Oncology|December 18, 2024
Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancerPeipei Xie, Xiaoli Zhang, Tianyi Liu, et al.
Cancer Letters|February 28, 2024
Circulating tumor cell clustering modulates RNA splicing and polyadenylation to facilitate metastasisQuanyou Wu, Zhaoru Gu, Bingqing Shang, et al.
Molecular Therapy. Oncology|April 16, 2025
Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activationDuo Wan, Qi Zhang, Zhenrong Yang, et al.
Journal of Hematology & Oncology|November 22, 2024
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinomaQi Zhang, Xiaoli Zhang, Zhuoheng Lv, et al.
Molecular Biomedicine|December 19, 2025
Peripheral TERT- positive leukocytes as a biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progressionQi Zhang, Xiaoli Zhang, Guoliang Li, et al.
BMC Medicine|October 31, 2022
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironmentDefeng Kong, Zhenrong Yang, Guoliang Li, et al.
Theranostics|November 28, 2022
Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapyQuanyou Wu, Xiao Hu, Xiaoli Zhang, et al.
Pageof 2